Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The poliovirus type 3 capsid protein from the Sabin strain forms part of an attenuated live-virus vaccine that safely induces immunity against polio through robust antibody responses targeting its structural components while carrying a low risk profile when administered appropriately. Its structure-function relationship underpins both its effectiveness as a vaccine antigen and rare risks associated with genetic reversion during human replication cycles.
Antibody neutralization of viral infectivity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poliovirus Type 3 Capsid Protein (Sabin Strain).